Nathan Stasko

Algemeen Directeur bij

Vast Therapeutics, Inc.

Health Technology

Profiel

Nathan Stasko was the founder of NVN Liquidation, Inc. since 2006, serving as President, Director & Chief Scientific Officer from 2017 to 2019.
Dr. Stasko is currently the Chief Executive Officer & Director at Vast Therapeutics, Inc. since 2022.
Formerly, Dr. Stasko was a Director at KNOW Bio LLC.

Actieve functies van Nathan Stasko

Bedrijven	Functie	Begin
Vast Therapeutics, Inc. Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections	Algemeen Directeur	01-03-2022

Alle actieve functies van Nathan Stasko

Eerdere bekende functies van Nathan Stasko

Bedrijven	Functie	Einde
NVN LIQUIDATION, INC.	Algemeen Directeur	05-06-2017
KNOW Bio LLC KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies	Directeur/Bestuurslid	-

Ervaring van Nathan Stasko in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Nathan Stasko in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	3
NVN Liquidation, Inc. NVN Liquidation, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops treatment for nitric oxide’s immunomodulatory & anti microbial mechanisms	Health Technology
KNOW Bio LLC KNOW Bio LLC Pharmaceuticals: MajorHealth Technology Develops and produces nitric oxide-based therapies	Health Technology
Vast Therapeutics, Inc. Vast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical stage biotechnology company which develops inhalable therapeutics to treat chronic infections	Health Technology